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ABSTRACT
The chromosomal location of the SCCmec ele-
ments containing mecA allows the identiﬁcation of
methicillin-resistant Staphylococcus aureus (MRSA)
strains by PCR ampliﬁcation of a sequence cov-
ering the right junction of the SCCmec elements
and the adjacent chromosomal region encoding
the species-speciﬁc ORFX. MRSA strains can be
identiﬁed speciﬁcally using one forward primer,
with only one or two mismatches, targeting the
SCCmec elements of different types, and one
reverse primer targeting the orfX region.
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The emergence and spread of methicillin-resistant
Staphylococcus aureus (MRSA), both as a nosoco-
mial pathogen and, more recently, in the commu-
nity, are matters of concern worldwide. S. aureus
acquires methicillin resistance by insertion into
the chromosome of a mobile genetic element,
designated staphylococcal cassette chromosome
(SCCmec), carrying the mecA gene. This gene
encodes an additional penicillin-binding protein,
PBP2a, which is not inhibited by existing b-lactam
antibiotics [1]. At least ﬁve different types of
SCCmec elements have been described, character-
ised by different classes of site-speciﬁc recombin-
ase genes (ccr complex), the mec gene complex,
insertion sequences and, in two cases, transposon
Tn554 [2,3]. SCCmec elements are ﬂanked by
incomplete inverted repeats, and are integrated
at a speciﬁc site (attBSCC) in the S. aureus
chromosome, which is located at the 3¢-end of
orfX [4].
PCR-based detection of MRSA has mostly been
based on individual ampliﬁcation of an S. aureus-
speciﬁc gene and mecA, as described recently for a
duplex real-time PCR with mecA- and nuc-speciﬁc
primers [5]. This approach is not immediately
applicable to the detection of MRSA from non-
sterile clinical specimens, which often contain
both S. aureus and methicillin-resistant coagulase-
negative staphylococci (CNS), thereby potentially
yielding false-positive results. An alternative
approach involves the selective immunomagnetic
enrichment of S. aureus and a subsequent multi-
plex PCR [6]. A further possibility is the ampli-
ﬁcation of a sequence covering both SCCmec and
the S. aureus-speciﬁc orfX region. Because of the
sequence differences at the right extremity of
the SCCmec elements, the assay described by
Huletsky et al. [7] uses ﬁve different primers to
target SCCmec types I–V and one primer for orfX.
However, the emergence of new SCCmec types,
especially among community-acquired MRSA [8],
may require the use of additional primers.
Following comparison of sequences at the right
junction of SCCmec and orfX, a 16-bp region of
relatively high homology was found, with only 1
or 2 bp differences between the SCCmec elements
of types I–V (Table 1). The present study des-
cribes the use of a PCR assay, with this sequence
as the forward primer and a highly conserved
sequence in orfX as the reverse primer, to identify
MRSA containing different types of SCCmec
elements. The primer sequences used in this
assay were: rjmec (forward), 5¢-TAT-
GATATGCTTCTCC (positions 57641–57656,
accession number D86934); and ORFX1r (reverse),
5¢-AACGTTTAGGCCCATACACCA (58042–
58022, D86934).
The S. aureus reference strain used was
NCTC 8325. Reference strains of MRSA contain-
ing SCCmec elements of types I–V were
NCTC 10442 (I), N315 (II), 85 ⁄ 2082 (III), 1155 ⁄ 93
(IV) and WIS (V). The reference strain for S. aureus
containing SCCmec cap1 was strain M. Reference
strains of CNS were: S. auricularis, ATCC33753; S.
capitis, CCM2734; S. capitis subsp. ureolyticus,
ATCC49326; S. caprae, CCM3573; S. carnosus,
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DSM20501; S. chromogenes, CCM3387; S. cohnii
cohnii, CCM2736; S. cohnii ureolyticus, ATCC49330;
S. delphini, DSM20771; S. epidermidis, CCM2124;
S. equorum, DSM20674; S. felis, ATCC49168;
S. gallinarum, CCM3572; S. haemolyticus,
CCM2737; S. hominis, DSM20328; S. hyicus,
CCM2368; S. intermedius, CCM5739; S. kloosii,
DSM20676; S. lugdunensis, ATCC43809; S. muscae,
CCM4175; S. saprophyticus, CCM883; S. schleiferi
coagulans, GA211; S. schleiferi schleiferi,
ATCC43808; S. sciurii, ATCC29062; S. simulans,
CCM2705; S. warneri, CCM2370; S. xylosus,
CCM2738; S. caseolyticus, ATCC13548; S. lentus,
CCM2598; and S. arlettae, DSM20672.
The clinical isolates of methicillin-susceptible S.
aureus (MSSA) and MRSA investigated were sent
from representative regions in Germany to the
authors’ laboratory, which is the national refer-
ence centre for typing of staphylococci. The
MRSA isolates were characterised by multilocus
sequence typing according to Enright et al. [9] and
by SCCmec typing using PCR according to Okuma
et al. [10]. Subtypes of type IV (a–d) were deter-
mined as described by Huletzky et al. [7]. The
clinical isolates of different species of CNS
(n = 80) originated from blood cultures of patients
showing symptoms of intravenous catheter-
related septicaemia.
Total cellular DNA was prepared from staphy-
lococci grown overnight on blood agar plates and
suspended in NaCl 0.9% w ⁄ v to a density
corresponding to a 0.5 · McFarland standard.
After treatment with lysostaphin (200 lg ⁄mL),
DNA was prepared using the DNeasy tissue kit
(Quiagen, Hilden, Germany) according to the
manufacturer’s instructions. Approximately
10 ng of DNA in a volume of 0.5 lL was added
to a 25-lL PCR mixture containing 2.5 pmol of
each primer and 200 lM each dNTP in 10 mM
Tris-HCl, pH 9.0, 1.5 mM MgCl2, 500 mM KCl.
The reaction was started by the addition of 1.3 U
of rTaq DNA polymerase (Amersham Pharmacia
Biotech, Freiburg, Germany). The thermal cycling
protocol (MJ Research PTC-200 thermocycler;
Biozym, Markrodendorf, Germany) comprised
94C for 3 min, followed by 30 cycles of 94C for
30 s, 55C for 30 s and 72C for 30 s, with a ﬁnal
extension at 72C for 4 min. The PCR products
were visualised following agarose gel electro-
phoresis.
With the use of primers rjmec and ORFX1r,
PCR products of c. 400 bp were obtained from the
reference strains containing SCCmec elements of
types I, II, III, IV and V, and from all clinical
MRSA isolates investigated. A representative set
of PCR products is shown in Fig. 1. The results
Table 1. DNA sequences at the
right junction of different types of
SCCmec elements
SCCmec type Reference strain Sequence Position; accession numbera
I NCTC 10442 5¢-TATGATAAGCTTCTCC 38855–38870; AB033763
II N315 5¢-TATGATATGCTTCTCC 57651–57656; D86934
III 85 ⁄ 2082 5¢-TATGATACGCTTCTCC 29582–29597; AB047089
IVa CA05 5¢-TATGATATGCTTCTCC 25210–25225; AB063172
Ivb JCSC1978 5¢-TATGATATGCTTCTCC 21207–21222; AB063173
Ivc MR108 5¢-TATGATATGCTTCTCC 30555–30570; AB096217
V WIS 5¢-TATGATACGCCTCTCC 892–877; AB121219
aAccession numbers: AB033763, S. aureus DNA, type I SCCmec; D86934, S. aureus DNA, resistance island type II
SCCmec; AB047089, S. aureus DNA, right extremity of type III SCCmec; AB063172, S. aureus DNA, type IV SCCmec,
strain CA05; AB063173, S. aureus DNA, type IV SCCmec, strain JCSC1978; AB09621, S. aureus DNA, type IVc
SCCmec, strain MR108; AB121219, S. aureus DNA, type V SCCmec, strain JCSC3624.
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Fig. 1. PCR products obtained with the rjmec–ORFX1r
primer set. Lanes: 1, NCTC 10442 (I); 2, N315 (II); 3,
85 ⁄ 2082 (III); 4, 1155 ⁄ 93 (IV); 5, methicillin-susceptible
Staphylococcus aureus (MSSA), NCTC 8325; 6, MSSA,
2639 ⁄ 04; 7, MSSA, 1567 ⁄ 02; 8, MSSA, S. aureus M
(SCCcap1); 9, methicillin-resistant Staphylococcus epidermidis
(MRSE), S. epidermidis 208; 10, methicillin-susceptible
Staphylococcus epidermidis (MSSE), S. epidermidis CCM2124;
11, S. delphinii DSM20771; M, molecular size standard.
SCCmec types are given in parentheses.
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obtained with DNA from clinical MRSA and
MSSA isolates, as well as CNS, are shown in
Table 2. MRSA strains of MLST types ST05, ST22,
ST45, ST228, ST254 and ST247 are the major
epidemic clones in Central Europe. MRSA strains
of types ST01, 30 and 80 are community-acquired
MRSA strains that have emerged recently [8]. The
PCR approach also allowed the detection of
MRSA strains with as yet unidentiﬁed SCCmec
elements (Table 2) that yielded negative results
with PCRs targeting the known ccr complexes
[3,7] and sequences of types IVa, IVb, IVc, IVd
and V. The PCR produced no ampliﬁcation
product for 100 clinical MSSA isolates of different
origins with different SmaI macrorestriction pat-
terns. The PCR was also negative with the
reference strains of CNS, with the exception of
the S. delphinii reference strain, which gave a weak
positive reaction (Fig. 1); however, this PCR
product did not hybridise with a mecA-speciﬁc
probe (data not shown). Furthermore, the PCR
was negative with 130 clinical isolates of CNS, 90
of which contained mecA.
Detection systems for MRSA that are based on
reverse blotting and use an MRSA-speciﬁc cap-
ture probe require smaller amplimers. This can be
achieved by using primer ORFX2r (5¢-AT-
GACATTCCCACATCAAATC; positions 38942–
38922; accession number AB033767), which yields
an 89-bp amplimer.
The advantage of the PCR test described in this
study is the use of only one primer set for the
detection of MRSA belonging to a variety of
different SCCmec types. However, the speciﬁcity
of this method may be an issue for strains of S.
aureus containing a staphylococcal cassette chro-
mosome lacking mecA, as described for SCCcap1.
This element harbours the cap1 genes responsible
for production of a type 1 capsular polysaccharide
[11]. As expected, the PCR was positive for S.
aureus strain M harbouring SCCcap1 (Fig. 1).
However, S. aureus strains of capsular type 1 are
rare, with the most frequent being types 5 and 8
[12]. None of the 100 MSSA isolates of different
origins and with different SmaI macrorestriction
patterns were PCR-positive, yielding the c. 400 bp
product. Other SCC elements have been described
for CNS [13]. However, this will not interfere with
the PCR approach described here, since these
species differ from S. aureus in the chromosomal
sequences next to the 3¢ junction of the cassette.
Rapid detection of MRSA directly from clinical
specimens and nasal swabs is important for
timely and appropriate treatment and infection
control. In particular, screening of patients for
MRSA upon hospital admission must produce
quick results in order to be effective [14]. The
possible use of the PCR assay described here for
the direct detection of MRSA in clinical samples is
currently being investigated.
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ABSTRACT
This study reviewed 1787 episodes of peritoneal
dialysis (PD)-related peritonitis in 544 patients
between 1994 and 2003. The overall rate of
peritonitis was 0.68 episodes ⁄ year of PD, but
decreased from 1.10 to 0.46 episodes ⁄ year
between 1994 and 2003. The incidence of perito-
nitis caused by coagulase-negative staphylococci
declined between 1994 and 1998 from 0.21 to 0.06
episodes ⁄year of PD, coinciding with a reduction
in the use of spike PD sets. There was a 60.1%
response rate to antibiotics throughout the period,
but the percentage of cases that required modiﬁ-
cation of the initial empirical antibiotic regimen
rose from 13.6% to 58.7%, indicating that treat-
ment should be individualised.
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Peritonitis is the most important cause of treat-
ment failure in peritoneal dialysis (PD) patients
[1]. Peritonitis was common following the initial
development of PD, but the incidence has
decreased markedly during the past 15 years,
probably as a result of improvements in connec-
tion technology [2,3]. Peritonitis rates nowadays
are less than one episode ⁄ 20 patient-months in
most series [4,5]. The present study describes the
change in distribution of causative organisms in
PD-related peritonitis during a 10-year period in a
single centre in Hong Kong.
All episodes of PD-related peritonitis between
1994 and 2003 in the renal unit of the Prince of
Wales Hospital, Hong Kong, were reviewed. In
total, 1787 episodes of peritonitis in 544 patients
were identiﬁed. Data completeness was assured
by the computerised Renal Registry. A diagnosis
of peritonitis was based on at least two of the
following criteria [6]: (1) abdominal pain or
cloudy peritoneal dialysis efﬂuent (PDE); (2)
leukocytosis in PDE (white blood cells
> 100 ⁄mL); and (3) positive Gram-stain or culture
from PDE. Episodes with peritoneal eosinophilia
but with a negative bacterial culture were exclu-
ded. Bacterial culture of PDE was performed
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